National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

MDX-010

 A monoclonal antibody being studied in the treatment of certain types of cancer. MDX-010 is made in the laboratory and binds to the molecule CTLA-4 on T cells (a type of white blood cell). MDX-010 may block CTLA-4 and help the immune system kill cancer cells. Also called ipilimumab.



Previous Definitions:maytansinoid DM4-conjugated humanized monoclonal antibody huC242, MBL, MC1R, MDL 101,731, MDR modulator CBT-1
Next Definitions:MDX-060, mean, mean survival time, measles virus, measurable disease

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov